By Fineline Cube 
German pharmaceutical giant Bayer AG (ETR: BAYN) has completed a 70,000-square-foot expansion at its Myerstown, Pennsylvania manufacturing site, following a USD 44 million investment announced in 2022. This upgrade establishes the facility as the largest production hub within Bayer’s global Consumer Health division.
Historical Context and Product Portfolio
The Myerstown site, operational for over 75 years, produces well-known brands such as Bayer Aspirin, Aleve, Claritin, One A Day, Alka-Seltzer Plus, and Midol. These products are integral to Bayer’s Consumer Health portfolio, serving millions of customers globally.
Expansion Details
The expansion includes eight new automated packaging lines and advanced logistics systems. These enhancements significantly boost production efficiency and supply chain agility, supporting Bayer’s commitment to meeting growing consumer health demands.-Fineline Info & Tech